South-East Asia (WHO region) vs Syrian Arab Republic: Hepatitis B surface antigen (HBsAg) prevalence
South-East Asia (WHO region)
0.2%
in 2024
Syrian Arab Republic
2.9%
in 2024
South-East Asia (WHO region) rank
8th
Syrian Arab Republic rank
6th
Hepatitis B surface antigen (HBsAg) prevalence over time
- South-East Asia (WHO region)
- Syrian Arab Republic
How they compare
Syrian Arab Republic currently reports 2.9% against 0.2% in South-East Asia (WHO region), a difference of 2.7%.
That makes Syrian Arab Republic's figure about 14.5 times South-East Asia (WHO region)'s.
Across all 10 years both countries report, Syrian Arab Republic has been ahead every year.
South-East Asia (WHO region) ranks 8th and Syrian Arab Republic ranks 6th of 13 groups.
Syrian Arab Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South-East Asia (WHO region) | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 3.5% | 3.1% | Syrian Arab Republic |
| 2020s | 0.3% | 3.4% | 3.1% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, South-East Asia (WHO region) or Syrian Arab Republic?
- Syrian Arab Republic, at 2.9% against 0.2% in South-East Asia (WHO region) as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between South-East Asia (WHO region) and Syrian Arab Republic?
- 2.7%, with Syrian Arab Republic ahead.
- How many years of comparable data are there for South-East Asia (WHO region) and Syrian Arab Republic?
- 10 years are reported by both, from 2015 to 2024.
- How do South-East Asia (WHO region) and Syrian Arab Republic rank globally for hepatitis b surface antigen (hbsag) prevalence?
- South-East Asia (WHO region) ranks 8th and Syrian Arab Republic ranks 6th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.